What Causes Coccidiosis in Chickens: Etiology, Transmission, and Predisposing Factors in Flock Management
1. Introduction
Coccidiosis is a ubiquitous and economically significant enteric disease of domestic chickens caused by obligate intracellular apicomplexan parasites of the genus Eimeria (phylum Apicomplexa, family Eimeriidae) [1, 54]. The disease is characterized by a spectrum of clinical manifestations ranging from subclinical reductions in growth performance and feed efficiency to severe hemorrhagic enteritis, high morbidity, and mortality, particularly in young broiler and layer pullets [2, 79]. The global economic burden of coccidiosis is substantial, driven by losses in productivity, mortality, and the costs associated with prophylactic and therapeutic interventions [3, 4]. Understanding the precise etiology, transmission pathways, and the complex interplay of host, pathogen, and environmental factors that predispose flocks to clinical disease is fundamental to designing effective, sustainable control programs [1, 54].
This article provides a detailed, publication-grade review of the etiological agents of chicken coccidiosis, their biological life cycles, mechanisms of transmission, and the critical predisposing factors related to flock management that influence the onset and severity of disease. The discussion is grounded in the most recent peer-reviewed literature, with a focus on molecular pathogenesis, diagnostic advancements, and epidemiological modeling.
2. Etiology: The Genus Eimeria
Coccidiosis in chickens is caused by a complex of seven recognized species of Eimeria that are highly host-specific, with each species exhibiting a predilection for a specific region of the intestinal tract [1, 54]. The seven species are: Eimeria tenella, Eimeria necatrix, Eimeria acervulina, Eimeria maxima, Eimeria brunetti, Eimeria mitis, and Eimeria praecox [1, 82]. A cryptic species, Eimeria zaria, has also been characterized, expanding the known diversity of Eimeria infecting chickens [5]. The pathogenicity and site of infection vary markedly between species. E. tenella and E. necatrix are considered the most virulent, causing severe hemorrhagic lesions in the ceca and mid-jejunum, respectively [6, 7]. E. acervulina and E. maxima are associated with moderate to severe pathology in the duodenum and jejunum, while E. brunetti affects the lower intestine and rectum [8, 66].
2.1. Life Cycle and Developmental Stages
The Eimeria life cycle is monoxenous (direct), involving a single host, and is divided into three distinct phases: exogenous (sporulation), endogenous (schizogony and gametogony), and transmission [1, 79].
Exogenous Phase (Sporulation): Unsporulated oocysts are shed in the feces of infected birds. Under optimal environmental conditions (20-30 degrees Celsius, high humidity, and adequate oxygenation), these oocysts undergo sporulation to become infective [9, 79]. Sporulation involves the development of four sporocysts, each containing two sporozoites, within the oocyst wall [1]. This process is critical for transmission, as only sporulated oocysts are capable of initiating infection [9].
Endogenous Phase: Upon ingestion of a sporulated oocyst by a susceptible chicken, the mechanical action of the gizzard and enzymatic activity in the digestive tract release the sporocysts and subsequently the sporozoites [7, 1]. Sporozoites are highly motile and invade the intestinal epithelial cells. In E. tenella, sporozoites specifically target the crypt epithelium of the ceca [7]. Following invasion, the sporozoite transforms into a trophozoite and then undergoes multiple rounds of asexual replication (schizogony or merogony), producing merozoites [6, 1]. The number of schizont generations is species-specific; for example, E. tenella typically undergoes three generations of schizogony [6]. The second and third generations of merozoites are responsible for the extensive destruction of the intestinal epithelium, leading to the characteristic pathological lesions and clinical signs [6, 7]. The final asexual stage gives rise to gamonts (macrogametes and microgametes), which undergo sexual reproduction (gametogony) to form the unsporulated oocyst [39, 79].
2.2. Molecular Mechanisms of Pathogenesis
The pathogenesis of coccidiosis is driven by the direct cytolytic damage to enterocytes during schizogony, compounded by a robust host inflammatory response [10, 11, 42]. Key molecular mechanisms include:
Invasion and Host Cell Modulation: Eimeria species use a suite of specialized secretory organelles (micronemes, rhoptries, and dense granules) to mediate host cell attachment and invasion [7, 68]. The microneme protein EtMIC2 has been shown to play a dual role in promoting invasion and inhibiting host cell apoptosis through binding to the integrin ITGAV receptor [7, 68]. Overexpression of EtMIC2 can attenuate pathogenicity while enhancing oocyst production.
Immune-Mediated Pathology: The host immune response, particularly the activation of the NF-kappaB (NF-κB) pathway, is a major driver of intestinal inflammation and apoptosis [10, 11]. TRAF6, a target of gga-miR-7b, has been shown to promote E. tenella-induced inflammation and apoptosis by activating the NF-κB pathway [10]. Depletion of CD25+ cells has been shown to restore Th1, Th2, and Th17 responses, mitigating E. maxima infection [12]. This indicates that regulatory T cells play a role in suppressing protective immunity [12].
Oxidative Stress and Barrier Disruption: Infection induces significant oxidative stress, characterized by elevated levels of malondialdehyde and reduced glutathione peroxidase activity [11, 13, 42]. This oxidative damage, combined with the physical destruction of enterocytes, compromises the integrity of the intestinal epithelial barrier, leading to increased permeability, malabsorption, and secondary bacterial infections (e.g., necrotic enteritis) [13, 46, 78].
Gut Microbiota Dysbiosis: Eimeria infection causes a profound disruption of the cecal and intestinal microbiota [14, 39, 73]. A consistent finding is a reduction in beneficial Lactobacillus and Bifidobacterium populations and an increase in potentially pathogenic Clostridium and Enterobacteriaceae [14, 13, 39]. This dysbiosis exacerbates intestinal damage and can promote the proliferation of Clostridium perfringens, the etiological agent of necrotic enteritis [3, 78]. The gut metabolite Intestinimonas has been shown to inhibit E. tenella gametogenesis via regulation of EtGFAT.
3. Transmission Dynamics
Transmission of Eimeria is exclusively fecal-oral, occurring through the ingestion of sporulated oocysts from a contaminated environment [1, 9, 82]. The life cycle is direct, with no intermediate hosts or vectors required [1].
3.1. Environmental Contamination and Oocyst Survival
Oocysts are extremely resilient and can persist in the environment for extended periods, particularly in litter, soil, and on fomites [9, 82]. The sporulated oocyst is the only infective stage. The key factors influencing oocyst survival and transmission are:
Temperature and Humidity: Sporulation is optimal at 20-30 degrees Celsius and requires high humidity (greater than 70%) [9]. Low humidity and high temperatures (greater than 40 degrees Celsius) are lethal to oocysts [9].
Litter and Housing: Built-up litter in deep-pit or floor-based housing systems provides a favorable microclimate for oocyst sporulation and accumulation [9, 82]. The concentration of oocysts in the litter is a direct function of stocking density, bird age, and the frequency of litter removal [9, 82].
Fomites and Vectors: Oocysts can be mechanically transmitted by farm personnel (boots, clothing, equipment), insects (e.g., darkling beetles, flies), and rodents [1, 9]. The role of Staphylococcus aureus as a co-pathogen in the cecal microbiome has been explored, but its role in oocyst transmission is not established.
3.2. Dose-Response and Population Dynamics
The severity of an outbreak is directly proportional to the number of oocysts ingested (the infective dose) [2, 46, 79]. Low-level exposure can result in subclinical infection with the development of protective immunity, while high-level exposure leads to clinical disease [2, 79]. The population dynamics of Eimeria within a flock follow a predictable pattern: a lag phase (1-3 days post-infection), an exponential growth phase (3-5 days), and a peak shedding phase (5-7 days). The peak in oocyst shedding typically coincides with the most severe clinical signs.
4. Predisposing Factors in Flock Management
The transition from subclinical infection to clinical disease is heavily influenced by a complex interplay of management, nutritional, and immunological factors [15, 16, 49]. These predisposing factors are critical for understanding and controlling outbreaks.
4.1. Management and Environmental Stressors
Stocking Density and Overcrowding: High stocking density increases the fecal-oral contact rate, leading to a higher oocyst burden in the environment [9, 82]. Overcrowding also induces chronic stress, which is immunosuppressive [16, 49].
Litter Quality and Moisture: Wet litter, often a consequence of poor ventilation, high humidity, or enteric disease, creates an ideal environment for oocyst sporulation [9, 79]. Dry litter is a potent inhibitor of oocyst survival [9].
Feed Withdrawal and Nutritional Stress: Acute feed withdrawal, a common practice before processing or during disease outbreaks, has been shown to exacerbate coccidiosis [15, 16, 49]. Feed withdrawal disrupts the intestinal barrier, alters the gut microbiota, and increases susceptibility to Eimeria [15, 16, 49].
Temperature Stress (Heat Stress): Cyclic elevated ambient temperature (heat stress) is a well-documented predisposing factor [16, 58]. Heat stress compromises intestinal barrier integrity, reduces feed intake, and suppresses the immune response, making birds more susceptible to Eimeria [16, 58].
Concurrent Infections: Co-infection with other enteric pathogens, such as Clostridium perfringens (necrotic enteritis) or Salmonella spp., dramatically increases the severity of coccidiosis [3, 46, 78]. The presence of E. tenella has been shown to dose-dependently increase the susceptibility of broilers to Salmonella infection.
4.2. Nutritional and Dietary Factors
Dietary Iron Overload: Excessive dietary iron, often from contaminated feed or water, has been shown to exacerbate E. tenella infection by impairing barrier integrity and promoting gut microbiota dysbiosis [13].
Mycotoxin Contamination: Feed-borne mycotoxins, such as deoxynivalenol (DON), have a synergistic effect with Eimeria [17]. DON disrupts the intestinal epithelium and suppresses the immune response, increasing the severity of coccidiosis [17].
Protein and Amino Acid Balance: Arginine and methionine are critical for immune function and intestinal health [58, 65]. Supplementation with these amino acids has been shown to mitigate the negative effects of coccidiosis under heat stress.
Feed Particle Size: The physical form of the feed (mash vs. pellets) and particle size can influence the rate of passage and the exposure of the intestinal mucosa to Eimeria. Coarser particles may reduce the risk of infection by increasing gizzard activity and reducing the residence time of oocysts in the small intestine.
4.3. Host Genetics and Immunity
Breed Susceptibility: There is significant genetic variation in resistance to coccidiosis among different chicken breeds and lines [54, 61]. Native breeds of Bangladesh have been shown to be more susceptible to E. tenella than commercial broiler lines. The genetic basis of resistance is complex, involving multiple quantitative trait loci (QTLs) and immune-related genes.
Age and Immune Status: Young birds (3-6 weeks of age) are the most susceptible to clinical coccidiosis [1, 79]. Maternal antibodies provide some protection, but this wanes rapidly after the first week of life [1]. The development of protective immunity after a primary infection is strong but species-specific [1, 8].
Vaccination Status: The use of live-attenuated or non-attenuated Eimeria vaccines (e.g., oocyst-based or subunit vaccines) is a cornerstone of modern coccidiosis control [18, 4, 69]. Vaccination induces a controlled, low-level infection that primes the immune system, providing protection against subsequent high-level challenge [18, 4]. However, the efficacy of vaccination can be compromised by concurrent ionophore use or poor management [4].
4.4. Antimicrobial and Anticoccidial Resistance
The widespread and prolonged use of anticoccidial drugs (ionophores and synthetic chemicals) has led to the development of resistance in Eimeria populations [19, 20, 48, 52, 74]. Resistance is a major predisposing factor for clinical outbreaks.
Ionophore Resistance: Resistance to ionophores (e.g., monensin, salinomycin, maduramycin) is well-documented and is often mediated by mutations in target genes, such as those encoding phosphoglycerate mutase 1 and ribosomal protein L27 [20, 48, 74]. Cross-resistance between ionophores is common [5].
Synthetic Chemical Resistance: Resistance to synthetic chemicals (e.g., toltrazuril, sulfaclozine, diclazuril) is also emerging [19, 21, 52]. A study in Vietnam reported high levels of resistance to toltrazuril and sulfaclozine [19]. The molecular basis of resistance to these compounds is less well understood but may involve mutations in the target enzyme (e.g., dihydrofolate reductase for sulfonamides) [21].
Impact on Intestinal Recovery: Drug-resistant Eimeria strains cause more severe intestinal damage and delay recovery, as measured by histomorphometry and oocyst shedding [19, 20].
5. Diagnostic Approaches and Computational Modeling
Accurate diagnosis is essential for understanding the etiology and for implementing targeted control measures [22, 23, 24, 41, 44].
5.1. Traditional and Molecular Diagnostics
Oocyst Morphology and Fecal Flotation: Traditional diagnosis relies on the identification of oocysts in fecal samples using flotation techniques (e.g., saturated salt or sugar solutions) [1, 9]. Species identification is based on oocyst size, shape, color, and sporulation time [1].
Lesion Scoring: Post-mortem examination of the intestinal tract for characteristic lesions is a standard method for assessing the severity of infection [8, 79]. A standardized 0-4 lesion scoring system is used for each Eimeria species.
Molecular Diagnostics (PCR and Sequencing): Polymerase chain reaction (PCR) and high-throughput sequencing (e.g., amplicon sequencing) are the gold standard for species identification and for detecting drug resistance mutations [22, 23, 48, 83]. Multiplex recombinase polymerase amplification (RPA) combined with CRISPR/Cas12a has been developed for the rapid, field-deployable detection of seven Eimeria species [23].
Immunoproteomics and Biosensors: Cross-priming amplification (CPA) combined with lateral flow immunoassay biosensors has been developed for the rapid detection of Eimeria at the genus level and for the identification of the four most economically important species [22].
5.2. Computational and Predictive Modeling
Deep Learning for Oocyst Viability: Deep learning algorithms (e.g., convolutional neural networks) have been developed for the automated detection and viability assessment of Eimeria oocysts from microscopic images [24].
Epidemiological Modeling: Mathematical models, including Bayesian networks and agent-based models, are used to predict the risk of coccidiosis outbreaks based on environmental, management, and host factors [9, 2, 82]. These models are critical for informing risk-based surveillance and control strategies [9, 2].
Risk Factor Analysis: Multivariate logistic regression and spatial analysis have identified key risk factors for Eimeria prevalence, including farm size, biosecurity practices, litter management, and the use of anticoccidial drugs [60, 82, 83].
6. Conclusion
Coccidiosis in chickens is a multifactorial disease driven by a complex interplay between the biology of the Eimeria parasite, the host immune response, and many environmental and management factors. The etiological agents are highly host-specific, with a direct life cycle that is exquisitely adapted to the intensive conditions of modern poultry production. Transmission is driven by the accumulation and survival of oocysts in the litter, and the transition from subclinical to clinical disease is heavily influenced by stressors such as overcrowding, heat stress, feed withdrawal, and nutritional imbalances. The emergence of drug resistance and the availability of advanced molecular diagnostics and computational modeling tools are reshaping the landscape of coccidiosis control. A holistic, integrated approach that combines biosecurity, vaccination, strategic drug use, and nutritional management is essential for the sustainable control of this pervasive disease.
References
[1] Nguyen BT, Flores RA, Kim T et al. Understanding Eimeria infection for the treatment and prevention of chicken coccidian parasites. Front Cell Infect Microbiol. 2026.
[2] Ithurbide M, Pinard van der Laan MH, Gao Y et al. Understanding the direct and indirect impacts of disease response phenotypes on chicken coccidiosis epidemiology: A modelling approach. PLoS One. 2026.
[3] Agunos A, Gow S, Reid-Smith R. Trends in Necrotic Enteritis and Coccidiosis Control Practices in Canadian Poultry Flocks, 2018-2023. Avian Dis. 2025.
[4] Estensmo EL, Granstad S, Stevens KB et al. A new era of coccidiosis control: Eimeria and Clostridium perfringens dynamics in vaccinated broiler flocks after the ionophore phase-out in Norway. Prev Vet Med. 2026.
[5] Raffaelli M, Jaramillo-Ortiz JM, Vasilogianni M et al. Ionophore susceptibility of Eimeria zaria: First characterisation in a cryptic Eimeria species of chickens. Vet Parasitol. 2026.
[6] He Y, Wan X, Wang X et al. Integrative comparative genomics and transcriptomics reveal key roles of SAG17 and SAG23 in early-stage virulence divergence of Eimeria tenella. Vet Res. 2026.
[7] Cui KL, Guo LL, Lei X et al. Pathogenic mechanism of Eimeria tenella EtMIC2 promotes Eimeria tenella invasion and inhibits host cell apoptosis through binding to the ITGAV receptor. Poult Sci. 2026.
[8] Kang JH, Tan JJ, Wang RZ et al. Pathogenicity, immunogenicity, and cross-protective efficacy of representative Eimeria brunetti strains in Chinese yellow-feathered broilers: an in vivo evaluation. Poult Sci. 2026.
[9] Bachene MS, Hentabli S, Khelouia A et al. Environmental contamination by Eimeria spp. and coccidiosis risk modeling in broiler farms of Medea province, Algeria. Comp Immunol Microbiol Infect Dis. 2026.
[10] Tang J, Zhang J, Tang M et al. TRAF6, a gga-miR-7b Target, Promotes Eimeria tenella-Induced Inflammation and Apoptosis in Chickens by Activating NF-κB Pathway. Biomolecules. 2026.
[11] Mohamed RA, Ali HA, Salem GA et al. Assessment of Quercetin and Thyme Oil Effect on Oxidative Stress Biomarkers and mRNA Expressions of Interleukin 6, 2, and 16 During Eimeria tenella Infection. Avian Dis. 2026.
[12] Pan Y, Pu X, Zhang Y et al. Depletion of CD25(+) cells restores Th1, Th2 and Th17 responses and mitigates Eimeria maxima infection in chickens. Poult Sci. 2026.
[13] Guo Y, Fu F, He X et al. Dietary iron overload exacerbates intestinal damage induced by Eimeria tenella infection in broilers via impaired barrier integrity and gut microbiota dysbiosis. Poult Sci. 2026.
[14] Yuke Z, Chen X, Abuzeid AMI et al. Gentiana scabra mitigates Eimeria tenella-induced Coccidiosis by regulating the gut microbiota-metabolome and strengthening the intestinal barrier. Poult Sci. 2026.
[15] Froebel LE, Watson BY, Rincker MJ et al. Temporal effects of a botanical feed additive and experimental housing methods in broilers exposed to an acute feed withdrawal period prior to coccidiosis inoculation. Poult Sci. 2026.
[16] Froebel LE, Rincker MJ, Dilger RN. Effects of dietary saponin and polyphenol supplementation in broiler chickens exposed to multiple mild stressors of cyclic elevated ambient temperature, feed withdrawal, and coccidiosis infection. Poult Sci. 2026.
[17] Paneru D, Sharma MK, Shi H et al. Interactive effects of the feed-borne mycotoxin deoxynivalenol and a mixed-species Eimeria challenge on layer pullets during the transition to lay. Poult Sci. 2026.
[18] Wang F, Zhang X, Feng Y et al. A novel dual-target fusion vaccine simultaneously targeting WFBI and WFBII components elicits synergistic protection against Eimeria necatrix. Poult Sci. 2026.
[19] Na TT, Hoa NT, Hung PHS et al. Evaluation of Toltrazuril and Sulfaclozine resistance in chicken coccidiosis in Vietnam and its impact on intestinal recovery. Vet Res Commun. 2026.
[20] Bai J, Zhao Q, Xiao K et al. Phosphoglycerate mutase 1 is implicated in maduramycin resistance and host cell invasion in Eimeria tenella. Vet Parasitol. 2026.
[21] Pham HSH, Nguyen TH, Le DP et al. Evaluation of the therapeutic efficacy of the sulfamidine-diaveridine combination against Vietnamese field isolate of Eimeria spp. in broiler chickens. Vet Parasitol. 2026.
[22] Wang YX, Wu ZX, Wang ZR et al. Cross-priming amplification strategy-assisted lateral flow immunoassay biosensors for the rapid detection of chicken Eimeria parasites at genus-level and identification of the four most economically important species. Poult Sci. 2026.
[23] Guo L, Cui K, Yang Y et al. Field-deployable multiplex RAA-CRISPR/Cas12a platform rapidly and simultaneously detects seven Eimeria species in chickens. Poult Sci. 2026.
[24] Park HW, Valente MJ, Fournet V et al. Deep learning-based detection and viability assessment of Eimeria oocysts. Poult Sci.
[25] Aydin R, Tegün E, Özüiçli M et al. Efficacy of in ovo and drinking water delivery of Lactobacillus acidophilus and Enterococcus faecium against Eimeria infection in broiler chickens. Exp Parasitol. 2026.
[26] Iqbal S, Tanveer S, Allaqaband SM et al. Lavender essential oil as a novel anticoccidial agent: First report from in-vitro and in-vivo studies of Lavandula angustifolia flowering plant grown in the Kashmir Himalayas. Microb Pathog. 2026.
[27] Yousfi S, Fennouh C, Touhami NAK et al. Effects of oregano extracts, alone or in combination with other biomolecules, on growth performances and parasitological parameters of broiler chickens challenged with Eimeria spp.: a meta-analysis. Avian Pathol. 2026.
[28] Xia Q, Weng S, Li K et al. Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens. Poult Sci. 2026.
[29] Lee JH, Kim DH, Vu VA et al. Effects of phytogenic feed additive on growth performance, gut health, and antioxidant capacity in broiler chickens challenged with pathogenic Eimeria tenella. Poult Sci. 2026.
[30] Felici M, de Hoest-Thompson C, Tugnoli B et al. Bioluminescence-based in vitro assay for rapid and quantitative anticoccidial screening. Front Cell Infect Microbiol. 2026.
[31] Ma Y, Dai L, Yu X et al. Anticoccidial activity and its potential Mechanisms of Stemona tuberosa against Eimeria tenella: In Vivo and In Vitro Investigations and Host Intestinal Protection. Vet Parasitol. 2026.
[32] Li J, Sun X, Tian E et al. Portulaca oleracea L. extract repairs chicken cecal barrier damage caused by Eimeria tenella. Poult Sci. 2026.
[33] Akter N, Dao TH, Jahan AA et al. Nutritional strategies to mitigate sub-clinical coccidiosis in Eimeria-challenged broilers. Poult Sci. 2026.
[34] Park I, Nam H, Ravichandran S et al. Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima. Poult Sci. 2026.
[35] Chhetri S, Singh DK, Tiwari BB et al. Effect of Probiotic and Synbiotic Supplementation on Growth Performance, Serum Parameters and Gut Histomorphometry in Broiler Chickens Challenged With Eimeria. Vet Med Sci. 2026.
[36] Niu Z, Zhao J, Dou K et al. The construction of recombinant DNA vaccine pVAX-ROP27-IL-2-IFN-γ and its immune enhancement effect against Eimeria tenella. Poult Sci. 2026.
[37] Hafeez A, Saleem U, Naz S et al. Effects of Betaine on Performance, Blood Biochemistry, Nutrient Utilization and Gut Health in Coccidia-Infected Broilers. Vet Med Sci. 2026.
Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.